Priority Date: 02.12.08 (GB 20080022011)

Treatment of autoimmune disease by modulating Annexin-1 (lipocortin 1)

  • Application ID: EP15152742
  • Status: EXAMINATION IN PROGRESS

Attorney

operating since 1906
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 192 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 02.12.2008 - Priority Date (GB 20080022011)
  • 01.07.2015 - Publication A2 (EP2889312)
  • 21.10.2015 - Publication A3 (EP2889312)